Sanofi Pasteur’s dengue vaccine wins Best New Drug Award at the 12th Annual Scrip Awards event.
The Scrip Awards acknowledge and commend the pharmaceutical sector’s stand-out performers across all areas of the industry, recognising both corporate and individual achievements.
Sanofi Pasteur’s dengue vaccine won the HUYA Bioscience’s Best New Drug Award at the 12th Annual Scrip Awards, during the awards ceremony presented by award-winning broadcaster Jeremy Vine at the Grosvenor House Hotel on the 30th November 2016.
The Best New Drug Award recognises excellence in pharmaceutical development. Launching an innovative new drug is the most important function of the industry and is the culmination of years of costly and uncertain R&D. This award celebrates a newly approved drug that has made the biggest impact in its field over the past year.
Sanofi Pasteur’s vaccine is the first against dengue, a disease that affects 390 million people each year. It is indicated to prevent dengue caused by all four of the virus serotypes and is the culmination of over two decades of scientific innovation and collaboration, with 40,000 volunteers participating in the development program.
The judges said: “Sanofi Pasteur’s vaccine was the worthy winner of this award as it clearly addresses a major medical need for a large number of poor people across the world. This vaccine is the result of a very lengthy R&D process and fact that this vaccine has shown to be effective against all four strains of the virus is extremely impressive.”
Recipients are chosen from entries adjudicated by a distinguished judging panel which this year included: Sir Gregory Winter, Master, Trinity College Cambridge; Brian Hargreaves, Independent Adviser, Consultancy; Laurie A. Halloran, President, Halloran Consulting; Ray Winquist, Senior leader for target identification, drug discovery and development, Pharma Research and Discovery Consulting; Dr Laura Brown, Director, LB Training and Development; Dennis Gillings CBE, Co-founder and former Executive Chairman, QuintilesIMS; Professor Trevor Jones CBE, Chairman, Simbec-Orion Group; Viren Mehta, Founder and managing member, Mehta Partners; Dr Alison Messom, Chairman Institute of Clinical Research, Director ALM Consultancy; Phornvit Phacharintanakul, Chairman , Strategic Business Partners; Peter Pitts, President, Center for Medicine in the Public Interest; Dr Brian Tempest, Editor, Journal of Generic Medicines; Robert Spiegel, Founder, Spiegel Consulting; Robert Thong, Independent Consultant and Writer, SciTechStrategy and Andy Smith, Chief Investment Officer, Mann Bioinvest.
The Scrip Awards are managed by Scrip Intelligence, the premier source of information for the pharmaceutical industry. Scrip provides information, analysis and knowledge for business decision makers in a changing and increasingly complex pharmaceuticals environment.
To see the full list of Scrip Awards winners please visit: www.scripawards.com